BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18541601)

  • 1. The omega-3 index as a risk factor for coronary heart disease.
    Harris WS
    Am J Clin Nutr; 2008 Jun; 87(6):1997S-2002S. PubMed ID: 18541601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor.
    Harris WS
    Pharmacol Res; 2007 Mar; 55(3):217-23. PubMed ID: 17324586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations?
    Yuen AW; Sander JW; Flugel D; Patsalos PN; Browning L; Bell GS; Koepp MM
    Epilepsy Behav; 2008 Feb; 12(2):317-23. PubMed ID: 18068523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?
    von Schacky C
    Curr Opin Clin Nutr Metab Care; 2008 Mar; 11(2):94-9. PubMed ID: 18301082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids: how can they be used in secondary prevention?
    Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Atheroscler Rep; 2008 Dec; 10(6):510-7. PubMed ID: 18937899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia.
    Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495
    [No Abstract]   [Full Text] [Related]  

  • 8. [Omega-3 fatty acids in cardiology. Latest developments].
    von Schacky C
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():97-101. PubMed ID: 17955786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease.
    Weisman D; Motro M; Schwammenthal E; Fisman EZ; Tenenbaum A; Tanne D; Adler Y
    Isr Med Assoc J; 2004 Apr; 6(4):227-32. PubMed ID: 15115262
    [No Abstract]   [Full Text] [Related]  

  • 10. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
    Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
    Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The omega-3 index: from biomarker to risk marker to risk factor.
    Harris WS
    Curr Atheroscler Rep; 2009 Nov; 11(6):411-7. PubMed ID: 19852881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients.
    Harris WS; Reid KJ; Sands SA; Spertus JA
    Am J Cardiol; 2007 Jan; 99(2):154-8. PubMed ID: 17223410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
    Kar S
    Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Omega-3 Index: a new risk factor for death from coronary heart disease?
    Harris WS; Von Schacky C
    Prev Med; 2004 Jul; 39(1):212-20. PubMed ID: 15208005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: observations from 160,000 patients.
    Harris WS; Pottala JV; Varvel SA; Borowski JJ; Ward JN; McConnell JP
    Prostaglandins Leukot Essent Fatty Acids; 2013 Apr; 88(4):257-63. PubMed ID: 23375840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers.
    Judé S; Roger S; Martel E; Besson P; Richard S; Bougnoux P; Champeroux P; Le Guennec JY
    Prog Biophys Mol Biol; 2006; 90(1-3):299-325. PubMed ID: 16005051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels.
    Amin AA; Menon RA; Reid KJ; Harris WS; Spertus JA
    Psychosom Med; 2008 Oct; 70(8):856-62. PubMed ID: 18842751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of omega-3 Fatty Acid intake to other dietary factors known to reduce coronary heart disease risk.
    Cundiff DK; Lanou AJ; Nigg CR
    Am J Cardiol; 2007 May; 99(9):1230-3. PubMed ID: 17478148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 fatty acids vs. cardiac disease--the contribution of the omega-3 index.
    Von Schacky C
    Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):93-101. PubMed ID: 20196973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.